Citations: CARVALHO,RICARDO F.S.; ULFGREN,ANN KRISTIN; ENGSTROM,M.A.R.I.; KLINT,ERIK af; NILSSON,G.U.N.N.. CD153 in Rheumatoid Arthritis: Detection of a Soluble Form in Serum and Synovial Fluid, and Expression by Mast Cells in the Rheumatic Synovium. The Journal of Rheumatology 2009;36:501-507. (Link)
References: Shimozato,O.; Takeda,K.; Yagita,H.; Okumura,K.. Expression of CD30 ligand (CD153) on murine activated T cells. Biochem.Biophys.Res.Commun. 1999;256:519-526. (Link)
Armitage,R.J.. CD153. J.Biol.Regul.Homeost.Agents 2000;14:142-144. (Link)
Hargreaves,P.G.; Al-Shamkhani,A.. Soluble CD30 binds to CD153 with high affinity and blocks transmembrane signaling by CD30. Eur.J.Immunol. 2002;32:163-173. (Link)
Phillips,T.A.; Ni,J.; Hunt,J.S.. Cell-specific expression of B lymphocyte (APRIL, BLyS)- and Th2 (CD30L/CD153)-promoting tumor necrosis factor superfamily ligands in human placentas. J.Leukoc.Biol. 2003;74:81-87. (Link)
Goldie-Cregan,L.C.; Croager,E.J.; Abraham,L.J.. Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression. Tissue Antigens 2002;60:139-146. (Link)
Cerutti,A.; Schaffer,A.; Goodwin,R.G.; Shah,S.; Zan,H.; Ely,S.; Casali,P.. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells. J.Immunol. 2000;165:786-794. (Link)